Facial Injectables Market – Restoring the Radiance of Youth
Facial injectable aid in rejuvenating facial skin by reducing or eliminating wrinkles, raising scar depressions, and enhancing lips. Facial injectable are products that include collagen fillers, hyaluronic acid fillers, and synthetic fillers such as calcium hydroxyl apatite. The use of injectable products such as hyaluronic acid increases skin hydration, improves skin, and protects from UV damage and has relatively low side effects. These factors are anticipated to drive the market growth over the forecast years. Moreover, increasing demand for products that enhance personal beauty, rising consciousness about aesthetics, introduction of cost-effective facial injectable, and growing inclination towards minimally invasive procedures is anticipated to fuel the market growth.
The global facial injectables market was valued at US$ 6,253.7 million in 2016 and is expected to exhibit a robust CAGR of 11.9% over the forecast period (2017–2025).
Figure 1. Global Facial Injectables Market Value (US$ Mn), by Region, 2016
Increasing preference for non-invasive procedures to augment market growth
Increasing demand for non-surgical procedures for facial rejuvenation and correction is expected to be a factor augmenting growth of the facial injectables market. For instance, according to the International Society of Aesthetic Plastic Surgery (ISAPS), 2017, surgical and non-surgical cosmetic procedures exhibited an overall increase of 9% from 2016-2017. ISAPS also stated that nonsurgical procedures including injectable accounted for around 8,548,597 in 2016, globally. According to the British Association of Aesthetic Plastic Surgeons, 2013, anti-ageing facelifts and brow lifts cosmetic operations exhibited a 17% rise as compared to the year 2012 globally, thus indicating rise in adoption of facial injectable.
North America is dominant in the global facial injectables market, owing to increasing awareness about advanced beauty treatments and growing emphasis about physical appearance. According to research by Galderma S.A., 2017, around 2 million women in the U.S. regularly undergo aesthetic injectable procedures, while around 17 million are considering aesthetic injectable treatment, thereby, leading to increasing demand for facial injectable. Also, according to the American Society of Aesthetic Plastic Surgery, 2016, an increase of 93% in non-surgical procedures was observed in men and women aged 35–55 years from 2011-2016. Moreover, launch of novel products in the region by key players is a major factor accelerating the market growth. For instance, in 2016, Allergan Plc., launched an additional product in Juvederm collection of fillers, Juvederm Volbella XC, for lip augmentation and for correction of perioral rhytids, referred as lipstick lines, in adults over the age of 21. Juvéderm Volbella XC is the only filler proven to last for one year in both the lips and perioral rhytids with optimal treatment.
Supportive government and non-government initiatives to accelerate the market growth
Various organizations are conducting educational programs, scientific meetings to provide knowledge about the latest research and procedures, in turn increasing awareness among patients and plastic surgeons, thus bolstering the market growth. For instance, the International Society of Aesthetic Plastic Surgery (ISAPS) is a professional organization for board-certified aesthetic plastic surgeons, dedicated to promote excellence in the field of aesthetic plastic surgery globally. The Society offers instructional courses, symposia, and educational programs, while the members of ISAPS have access to the most advanced techniques such as botulinum toxin and dermal fillers. Moreover, the American Academy of Facial Esthetics (AAFE) aims to provide information about non-surgical and non-invasive facial injectable techniques to healthcare professionals worldwide. AAFE is also committed to providing the best possible outcomes in areas of facial esthetics and facial pain treatment.
Key players are adopting collaborations and product launches strategies in order to address the unmet aesthetic needs thereby, providing physicians with new and better options, augmenting growth of facial injectables market. For instance, in 2017, Galderma collaborated with Colorescience to expand its skincare solutions for individuals that can be used in conjunction with conventional facial injectable aesthetic treatments.
Major players operating in the global facial injectables market are Allergan, Plc., Galderma S.A., Integra LifeSciences Corporation, Merz Pharma GmbH & Co. KGaA., Sanofi S.A., SciVision Biotech Inc., Sinclair Pharma Plc., Suneva Medical, Valeant Pharmaceuticals International, Inc., and Anika Therapeutics, Inc.
Facial injectable are called as facial fillers and are used in aesthetic therapeutic procedures to enhance facial looks. Facial injectable are used for smoothening wrinkles and scars on the face by filling the target area. Dermal fillers reduce wrinkles and add volume to the cheeks and lips and are injected directly in the wrinkles, while anti-wrinkle injections relax the muscles that cause creases. Facial injectable are mostly used for treating early signs of aging and increasing the aesthetic beauty. Some of the most commonly used facial injectable are collagens, hyaluronic acids, polymers, and botulinum toxin.
Major factors driving growth of the facial injectables market include increasing preference for non-surgical invasive cosmetics surgeries, increasing FDA approval of novel products, and rising demand for facial injectable to enhance aesthetic beauty. For instance, in 2017, Allergan Plc. received FDA approval for Juvederm Vollure for use in the U.S., while the product was previously available in Europe. Moreover, increasing promotional activities, rapidly developing healthcare infrastructure, and rising disposable income are the factors to propel the facial injectables market. For instance, according to the American Society for Aesthetic Plastic Surgery (ASAPS), 2016, the people in the U.S. spend over US$ 15 billion on combined surgical and non-surgical aesthetic procedures, accounting for an 11% increase over the year 2015. However, stringent regulations and side effects associated with injectable such as bruising, discoloration, and rashes are expected to negatively affect the market growth.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
*Browse 32 market data tables and 24 figures on "Facial Injectables Market - Global forecast to 2025”.
Finding it difficult to find the research that would cater to your business demands? Give us a chance to help you. One of our Research Consultants will connect to provide a customized solution.
Talk to our research consultant to design an exclusive report as per your research needs.
We aim to fulfil client's research demands with tailored research solutions.
We aim to provide research studies in quickest turnaround time and in a much cost effective manner.
We cover each industry from supply and demand side with an aim to provide a most holistic research study.
We strive to provide most accurate and reliable research findings in our research reports.